Cite
HARVARD Citation
Kasichayanula, S. et al. (2022). Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy. Clinical and translational science. 15 (8), pp. 1818-1837. [Online].